The Journal of Immunology, Vol 148, Issue 1 1-6, Copyright © 1992 by American Association of Immunologists

ARTICLES

Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins

R Buelow, RE O'Hehir, R Schreifels, TJ Kummerehl, G Riley and JR Lamb
ImmuLogic Pharmaceutical Corporation, Palo Alto, CA 94304.

The exotoxins of certain strains of Staphylococcus aureus strains are able both to stimulate potent proliferation and induce anergy in T lymphocytes expressing the appropriate T cell Ag receptor V beta gene elements. Although T cell activation by the S. aureus enterotoxins requires the presence of accessory cells bearing class II Ag of the MHC, unlike the peptide fragments of nominal Ag, they contact the external surfaces of both the class II MHC and TCR molecules. This paper investigates the immunologically active domains of S. aureus enterotoxin B (SEB) using truncated fragments of rSEB expressed as a fusion protein with protein A. The results of the experiments reported here indicate that the minimal fragment of SEB able to stimulate and induce anergy in hemagglutinin-reactive human T cells expressing V beta 3.1 gene elements is located in the amino-terminal portion of the molecule within residues 1-138. Deletion of the first 30 amino acid residues renders rSEB unable to stimulate T cells expressing V beta 3.1, whereas polyclonal T cells still respond to this molecule. This implies that the stimulation of several TCR-V beta families may be caused by the interaction with different regions of the toxin. The localization of immunologically active sites in the bacterial enterotoxins is needed to investigate both their biology and potential application as immunomodulatory agents.

This article has been cited by other articles:

				G. Arad, D. Hillman, R. Levy, and R. Kaempfer Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock J. Leukoc. Biol., June 1, 2001; 69(6): 921 - 927. [Abstract] [Full Text] [PDF]

				B. Hemmer, M. Vergelli, L. Tranquill, P. Conlon, N. Ling, H. F. McFarland, and R. Martin Human T-cell response to myelin basic protein peptide (83-99): Extensive heterogeneity in antigen recognition, function, and phenotype Neurology, October 1, 1997; 49(4): 1116 - 1126. [Abstract] [Full Text] [PDF]

				M. Pette, D. F. Pette, P. A. Muraro, E. Farnon, R. Martin, and H. F. McFarland Interferon-{beta} interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes Neurology, August 1, 1997; 49(2): 385 - 392. [Abstract] [Full Text] [PDF]

				J. R. Richert, E.D. Robinson, K. Camphausen, R. Martin, R. R. Voskuhl, M.A. Faerber, H.F. McFarland, and C. K. Hurley Diversity of T-cell receptor Valpha, Vbeta, and CDR3 expression by myelin basic protein-specific human T-cell clones Neurology, October 1, 1995; 45(10): 1919 - 1922. [Abstract] [Full Text] [PDF]

				D. Burger and J.-M. Dayer Inhibitory cytokines and cytokine inhibitors Neurology, June 1, 1995; 45(6_Suppl_6): S39 - S43. [Abstract] [Full Text] [PDF]